Axinn Advised Columbia Care in its $240M Acquisition of Green Leaf Medical
May 3, 2021
Axinn represented Columbia Care, a market leader in the two largest cannabis markets in the world (California and Colorado) in its acquisition of Green Leaf Medical, a privately held, fully-integrated cannabis multi-state operator based in the mid-Atlantic region for $240 million with the potential for additional performance-based milestone payments. Announced on December 22, 2020, the acquisition of Green Leaf will expand Columbia Care’s operational scale and footprint in four key, limited license markets by materially enhancing the scale and capabilities of its seed-to-sale operations. The deal closed on June 11, 2021.
The Axinn team was led by Lisl Dunlop and assisted by associate Sam Sherman.
Related Services
To subscribe to our publications, click here.
Featured Insights
Featured Insights
DC Bar: The DOJ's New Antitrust Whistleblower Rewards Program: An Overview and the Road Ahead
Speaking Engagement
Antitrust
Informa Antitrust Midwest 2026
Speaking Engagement
Antitrust
National LGBTQ+ Bar Association Lavender Law Conference and Career Fair 2026
Sponsorship
What’s Up? Enforcement Updates From the Middle East and Africa
Podcast
Antitrust
AHLA Annual Meeting & In-House Counsel Program
Sponsorship
Antitrust
Lexology In-Depth: Intellectual Property and Antitrust (2026)
Byline Articles
Intellectual Property
Tracking The Rare 'Quick Look' Win In FTC's Zillow-Redfin Suit
Byline Articles
Antitrust
Gleiss Lutz Annual Antitrust Law Conference
Speaking Engagement
Antitrust
What Top Law Firms Say New Lawyers Need in the AI Era
Media Mentions
What’s the Role of Communications Strategy in M&A? How Public Affairs Impacts Antitrust
Podcast
Antitrust
